Asandeutertinib
Asandeutertinib (Osimertinib-d3; AZD-9291-d3) is a epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, with antineoplastic effect[1].
Product Specifications
CAS Number
1638281-46-5
Product Name Alternative
Asandeutertinibum; Osimertinib-d3; AZD-9291-d3
UNSPSC
12352005
Target
EGFR
Type
Isotope-Labeled Compounds
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Purity
99.75
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
COC(C=C(C(NC(C=C)=O)=C1)N(C)CCN(C)C)=C1NC2=NC=CC(C(C3=CC=CC=C34)=CN4C([2H])([2H])[2H])=N2
Molecular Formula
C28H30D3N7O2
Molecular Weight
502.63
References & Citations
[1]Asandeutertinib (asandeutertinibum; Osimertinib-d3; AZD-9291-d3) . WHO Drug Information, Vol. 37, No. 4, 2023.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401670-500 1x 500 µL
NSE gamma (Neuron Specific Enolase, gamma) (Neuroendocrine Marker) (NSE-P2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC743735-100 1x 100 µL
PAX5 / BSAP (Early B-Cell Marker) (PAX5/3735), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
